Professor Peter Gray was appointed in 2003 as the inaugural Director of the Australian Institute of Bioengineering and Nanotechnology (AIBN) at the University of Queensland.
Prior to joining AIBN, he was Professor of Biotechnology and Director of the Bioengineering Centre at the University of New South Wales, and Senior Principal Research Fellow at the Garvan Institute of Medical Research in Sydney.
He has held academic positions at University College London, and at the University of California, Berkeley and has had commercial experience in the USA working for Eli Lilly and Co and the Cetus Corporation.
Professor Gray is a founder and a past President of the Australian Biotechnology Association (AusBiotech).
He serves on the Boards of Biopharmaceuticals Australia Pty Ltd, ACYTE Biotechnology Pty Ltd, the Advanced Water Management Centre, the Diamantina Institute for Cancer, Immunology and Metabolic Medicine, Engineering Conferences International (ECI) Inc, New York, and on a number of state and federal government committees in the fields of biotechnology, pharmaceuticals and education.
Professor Gray is an active researcher who has published and patented widely in the fields of bioengineering, the production of biopharmaceuticals and stem cell technology.